Unacylated ghrelin is not a functional antagonist but a full agonist of the type 1a growth hormone secretagogue receptor (GHS-R)

Molecular and Cellular Endocrinology

Volumn 274, Issue 1-2, 2007, Pages 30-34

  Gauna, Carlotta ^a   van de Zande, Bedette ^a   van Kerkwijk, Anke ^a   Themmen, Axel P N ^a   van der Lely, A J ^a   Delhanty, Patric J D ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antagonism; Ghrelin; GHS R

Indexed keywords

AEQUORIN; CALCIUM ION; GHRELIN; GROWTH HORMONE SECRETAGOGUE RECEPTOR; GROWTH HORMONE SECRETAGOGUE RECEPTOR TYPE 1A; UNACYLATED GHRELIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; IC 50; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; GLUCAGON; HUMANS; PEPTIDE HORMONES; PEPTIDES; RADIOLIGAND ASSAY; RECEPTORS, G-PROTEIN-COUPLED; SOMATOSTATIN;

EID: 34547157499     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.05.010     Document Type: Article

References (26)

1. Baldanzi G., Filigheddu N., Cutrupi S., Catapano F., Bonissoni S., Fubini A., Malan D., Baj G., Granata R., Broglio F., Papotti M., Surico N., Bussolino F., Isgaard J., Deghenghi R., Sinigaglia F., Prat M., Muccioli G., Ghigo E., and Graziani A. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J. Cell Biol. 159 (2002) 1029-1037
2. Bednarek M.A., Feighner S.D., Pong S.S., McKee K.K., Hreniuk D.L., Silva M.V., Warren V.A., Howard A.D., Van Der Ploeg L.H., and Heck J.V. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J. Med. Chem. 43 (2000) 4370-4376
3. Broglio F., Gottero C., Prodam F., Gauna C., Muccioli G., Papotti M., Abribat T., Van Der Lely A., and Ghigo E. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J. Clin. Endocrinol. Metab. 89 (2004) 3062-3065
4. Cassoni P., Papotti M., Ghe C., Catapano F., Sapino A., Graziani A., Deghenghi R., Reissmann T., Ghigo E., and Muccioli G. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J. Clin. Endocrinol. Metab. 86 (2001) 1738-1745
5. Cassoni P., Ghe C., Marrocco T., Tarabra E., Allia E., Catapano F., Deghenghi R., Ghigo E., Papotti M., and Muccioli G. Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur. J. Endocrinol. 150 (2004) 173-184
6. Chen C.Y., Inui A., Asakawa A., Fujino K., Kato I., Chen C.C., Ueno N., and Fujimiya M. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology 129 (2005) 8-25
7. Cheng K., Chan W., Barreto A.J., Convey E., and Smith R. The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3′,5′-monophosphate accumulation in rat primary pituitary cell culture. Endocrinology 124 (1989) 2791-2798
8. Dezaki K., Sone H., Koizumi M., Nakata M., Kakei M., Nagai H., Hosoda H., Kangawa K., and Yada T. Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance. Diabetes 55 (2006) 3486-3493
9. Gauna C., Meyler F.M., Janssen J.A., Delhanty P.J., Abribat T., van Koetsveld P., Hofland L.J., Broglio F., Ghigo E., and van der Lely A.J. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J. Clin. Endocrinol. Metab. 89 (2004) 5035-5042
10. Gauna C., Delhanty P.J., Hofland L.J., Janssen J.A., Broglio F., Ross R.J., Ghigo E., and van der Lely A.J. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J. Clin. Endocrinol. Metab. 90 (2005) 1055-1060
11. Gauna C., Delhanty P., van Aken M., Janssen J., Themmen A., Hofland L., Culler M., Broglio F., Ghigo E., and van der Lely A. Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor. Mol. Cell. Endocrinol. 251 (2006) 103-111
12. Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., Bhattacharya S., Carpenter R., Grossman A.B., and Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab. 87 (2002) 2988
13. Halem H.A., Taylor J.E., Dong J.Z., Shen Y., Datta R., Abizaid A., Diano S., Horvath T.L., and Culler M.D. A novel growth hormone secretagogue-1a receptor antagonist that blocks ghrelin-induced growth hormone secretion but induces increased body weight gain. Neuroendocrinology 81 (2005) 339-349
14. Hosoda H., Kojima M., Mizushima T., Shimizu S., and Kangawa K. Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. J. Biol. Chem. 278 (2003) 64-70
15. Kojima M., and Kangawa K. Ghrelin: structure and function. Physiol. Rev. 85 (2005) 495-522
16. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
17. Matsuda K., Miura T., Kaiya H., Maruyama K., Shimakura S., Uchiyama M., Kangawa K., and Shioda S. Regulation of food intake by acyl and des-acyl ghrelins in the goldfish. Peptides 27 (2006) 2321-2325
18. Matsumoto M., Hosoda H., Kitajima Y., Morozumi N., Minamitake Y., Tanaka S., Matsuo H., Kojima M., Hayashi Y., and Kangawa K. Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides. Biochem. Biophys. Res. Commun. 287 (2001) 142-146
19. Muccioli G., Pons N., Ghe C., Catapano F., Granata R., and Ghigo E. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. Eur. J. Pharmacol. 498 (2004) 27-35
20. Nanzer A.M., Khalaf S., Mozid A.M., Fowkes R.C., Patel M.V., Burrin J.M., Grossman A.B., and Korbonits M. Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway. Eur. J. Endocrinol. 151 (2004) 233-240
21. Smith R.G., Jiang H., and Sun Y. Developments in ghrelin biology and potential clinical relevance. Trends Endocrinol. Metab. 16 (2005) 436-442
22. Sopasakis V., Sandqvist M., Gustafson B., Hammarstedt A., Schmelz M., Yang X., Jansson P., and Smith U. High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes. Res. 12 (2004) 454-460
23. Thompson N.M., Gill D.A., Davies R., Loveridge N., Houston P.A., Robinson I.C., and Wells T. Ghrelin and des-octanoyl ghrelin promote adipogenesis directlyin vivo by a mechanism independent of GHS-R1a. Endocrinology 145 (2003) 234-242
24. Toshinai, K., Yamaguchi, H., Sun, Y., Smith, R.G., Yamanaka, A., Sakurai, T., Date, Y., Mondal, M.S., Shimbara, T., Kawagoe, T., Murakami, N., Miyazato, M., Kangawa, K., Nakazato, M., 2006. Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology.
25. van der Lely A.J., Tschop M., Heiman M.L., and Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev. 25 (2004) 426-457
26. van Kats J.P., Schalekamp M.A.D.H., Verdouw P.D., Duncker D.J., and Danser A.H.J. Intrarenal angiotensin II: interstitial and cellular levels and site of production. Kidney Int. 60 (2001) 2311-2317